Literature DB >> 9209003

Different hematological phenotypes caused by the interaction of triplicated alpha-globin genes and heterozygous beta-thalassemia.

C Camaschella1, A C Kattamis, D Petroni, A Roetto, P Sivera, L Sbaiz, A Cohen, K Ohene-Frempong, P Trifillis, S Surrey, P Fortina.   

Abstract

The pathophysiology and clinical severity of beta-thalassemia are related to the degree of alpha/non-alpha-chain imbalance. A triplicated alpha-globin gene locus can exacerbate effects of excess alpha-chains caused by a defective beta-globin gene, although this is not observed in all cases. Extensive studies on this condition are lacking. We report a group of 17 patients who are heterozygous for both the alpha alpha alpha(anti-3.7) allele and a mutation in the beta-globin gene cluster. Their clinical phenotypes varied: six had mild anemia with microcytosis and hypochromia, while 11 had more severe anemia with splenomegaly requiring splenectomy (three cases) and blood transfusions (four cases). Different phenotypes were also evident in the presence of the same beta-thalassemia mutation: in one family, two individuals had the same alpha- and beta-globin genotypes but presented with different hematologic phenotypes. In addition, the complex interaction involving a triplicated alpha-globin gene, beta39- and delta+27-thalassemia mutations is studied in a family with two siblings presenting with hemolytic anemia, normal Hb A2 and increased Hb F. Analysis of this series of patients suggests that additional genetic determinants play a role in modulating phenotypic expression in individuals with identical alpha- and beta-globin genotypes. Interaction with a triplicated alpha-gene can play a role in the clinical presentation of patients with defective beta-globin gene expression and should be considered in the diagnosis of atypical cases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9209003     DOI: 10.1002/(sici)1096-8652(199706)55:2<83::aid-ajh6>3.0.co;2-z

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  12 in total

1.  Does absolute excess of alpha chains compromise the benefit of splenectomy in patients with thalassemia intermedia?

Authors:  Giovanna Graziadei; Chiara Refaldi; Wilma Barcellini; Claudia Cesaretti; Elena Cassinero; Khaled M Musallam; Maria Domenica Cappellini
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

2.  Thalassemic erythrocytes release microparticles loaded with hemichromes by redox activation of p72Syk kinase.

Authors:  Emanuela Ferru; Antonella Pantaleo; Franco Carta; Franca Mannu; Amina Khadjavi; Valentina Gallo; Luisa Ronzoni; Giovanna Graziadei; Maria Domenica Cappellini; Francesco Turrini
Journal:  Haematologica       Date:  2013-09-13       Impact factor: 9.941

Review 3.  Beta-thalassaemia prototype of a single gene disorder with multiple phenotypes.

Authors:  Swee Lay Thein
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

4.  Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells.

Authors:  Laure A Moutouh-de Parseval; Dominique Verhelle; Emilia Glezer; Kristen Jensen-Pergakes; Gregory D Ferguson; Laura G Corral; Christopher L Morris; George Muller; Helen Brady; Kyle Chan
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

5.  Association of α globin gene quadruplication and heterozygous β thalassemia in patients with thalassemia intermedia.

Authors:  Maria Carla Sollaino; Maria Elisabetta Paglietti; Lucia Perseu; Nicolina Giagu; Daniela Loi; Renzo Galanello
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

6.  Thalassaemia intermedia: an update.

Authors:  Ali T Taher; Khaled M Musallam; Maria D Cappellini
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-08-29       Impact factor: 2.576

7.  The Frequency and Importance of Common α-globin Gene Deletions Among β-Thalassemia Carriers in an Iranian Population.

Authors:  Azam Moosavi; Ali M Ardekani
Journal:  Avicenna J Med Biotechnol       Date:  2017 Oct-Dec

8.  Challenges in the Diagnosis of Beta-thalassemia Syndrome: The Importance of Molecular Diagnosis.

Authors:  Nabilah Rameli; Marini Ramli; Zefarina Zulkafli; Mohd Nazri Hassan; Shafini Mohd Yusoff; Noor Haslina Mohd Noor; Suryati Hussin; Nor Khairina Mohamed Kamarudin; Yuslina Mat Yusoff; Rosnah Bahar
Journal:  Oman Med J       Date:  2022-01-31

9.  beta-Thalassaemia Major in a Spanish Patient due to a Compound Heterozygosity for CD39 C --> T/-28 A --> C.

Authors:  Soledad Gamarra; Guillermo Garcia-Effron; Carmen Monteserin; Isabel Lopez-Villar; Florinda Gilsanz; Joaquín Martinez-Lopez
Journal:  Adv Hematol       Date:  2009-07-28

10.  Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.

Authors:  Olivier Negre; Anne-Virginie Eggimann; Yves Beuzard; Jean-Antoine Ribeil; Philippe Bourget; Suparerk Borwornpinyo; Suradej Hongeng; Salima Hacein-Bey; Marina Cavazzana; Philippe Leboulch; Emmanuel Payen
Journal:  Hum Gene Ther       Date:  2016-02       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.